Takeda ORZEYFUL Launch Brings First Orexin Agonist for Narcolepsy Type 1 to U.S. Patients
The Takeda ORZEYFUL launch makes oveporexton, an oral orexin receptor 2 agonist, available by prescription in the U.S. for adults with narcolepsy type 1, with Accredo Specialty Pharmacy handling dispensing.
